You are here

2010

Original articles

Benga W.J., Krieger S. E., Dimitrova M., Zeisel M.B., Parnot M., Lupberger J., Hildt E., Luo G., Mclauchlan J., Baumert T.F., Schuster C. Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles. Hepatology, 2010, 51, 43-53.

Krieger S.E., Zeisel M.B., Davis C., Thumann C., Harris H.J., Schnober E.K., Mee C., Soulier E., Royer C., Lambotin M., Grunert F., Thi V.L.D., Dreux M., Cosset F.L., Mckeating Jane A., Schuster C., Baumert T.F. Inhibition of hepatitis C virus infection by anti-Claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations. Hepatology, 2010, 51, 1144-57.

Keymeulen B., Candon S., Fafi-Kremer S., Ziegler A., Leruez-Ville M., Mathieu C., Vandemeulebroucke E., Walter M., Crenier L., Thervet E., Legendre C., Pierard D., Hale G., Waldmann H., Bach J.F., Seigneurin J.M., Pipeleers D., Chatenoud L. Transient Epstein Barr virus reactivation in CD3 monoclonal antibody-treated patients. Blood, 2010, 115, 1145-55.

Marmier-Savet C., Larosa F., Legrand F., Witz B., Michallet M., Ranta D., Louvat P., Puyraveau M., Raus N., Tavernier M., Mathieu-Nafissi S., Hequet O., Pallandre J.R., Vitte F., Collonge-Rame M.A., Pouthier F., Bresson J.L., Deconinck E., Tiberghien P., Robinet E. G-C SF-induced anenploidy does not affect CD34+ cells and does not require cell division. Blood, 2010, 115, 910-1.

Dhillon S., Witteveldt J., Gatherer D., Owsianka A.M., Zeisel M.B., Zahid M.N., Rycklowska M., Foung S.K., Baumert T.F., Angus A.G.N., Patel A.H. Mutations within a conserved region of the Hepatitis C virus E2 glycoprotein that influence virus receptor interactions and sensitivity to neutralizing antibodies. J. Virol., 2010, 84, 5494-507.

Kremer S., Martern J.F., Bilger K., Lioure B., Fornecker Y., Stoll-Keller F., Namer I.J., Dietemann J.L., Fafi-Kremer S. EBV limbic encephalitis after allogenic hematopoietic stem cell transplantation. J. Neuroradiol., 2010, 37, 189-91.

Holl V., Xu K., Peressin M., Lederle A., Biedma M.E., Delaporte M., Decoville T., Schmidt S., Laumond G., Aubertin A.M., Moog C. Stimulation of HIV-1 replication in immature dendritic cells in contact with primary CD4 T-or B-lymphocytes. J. Virol., 2010, 84, 4172-82.

Bankwitz D., Steinmann E., Bitzegeio J., Ciesek S., Friesland M., Hermann E., Zeisel M.B., Baumert T.F., Keck Z.Y., Foung S.K., Pécheur E.I., Pietschmann T. Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site and protects conserved neutralizing epitopes. J. Virol., 2010, 84, 5751-63.

Bitzegeio J., Bankwitz D., Hüging K., Haid S., Brohm C., Zeisel M.B., Herrmann E., Iken M., Ott M., Baumert T.F., Pietschmann T. Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. PLoS Pathogens, 2010, 6:e1000978.

Bouzgarrou N., Hassen E., Gabbouj S., Schvoerer E., Ben Mami N., Triki H., Chouchane L. Lack of effect of tumor necrosis factor-alpha-308 G/A polymorphism on severity of liver fibrosis in Tunisian hepatitis C virus (HCV)-infected patients. Gastroentérol. Clin. Biol., 2010, 34, 297-304.

Fletcher N., Yang J.P., Farquhar M., Hu K., He Q., Dowd K., Ray S., Krieger S., Baumert T., Balfe P., Mckeating J.A., Wong-Staal F. Hepatitis C virus infection of neuroepithelioma cell lines. Gastroenterology, 2010, 139, 1365-74.

Lambotin M., Baumert T.F., Barth H. Distinct intracellular trafficking of hepatitis C virus in myeloid and plasmacytoid dendritic cells. J. Virol., 2010, 84, 8964-9.

Fafi-Kremer S., Fofana I., Soulier E., Carolla P., Meuleman P., Leroux-Roels G., Patel A.H., Cosset F.L., Pessaux P., Doffoël M., Wolf P., Stoll-Keller F., Baumert T.F. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation. J. Exp. Med., 2010, 207, 2019-31.

Fofana I., Krieger S.E., Grunert F., Glauben S., Xiao F., Fafi-Kremer S., Soulier E., Royer C., Thumann C., Mee C.J., Mckeating J.A., Dragic T., Pessaux P., Stoll-Keller F., Schuster C., Thompson J., Baumert T.F. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes. Gastroenterology, 2010, 139, 953-964.

Henry C., Deschamps M., Rohrlich P.S., Pallandre J.R., Remy-Martin J.P., Callanan M., Traverse-Glehen A., Grandclement C., Garnache-Ottou F., Gressin R., Deconinck E., Salles G., Robinet E., Tiberghien P., Borg C., Ferrand C. Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance. Blood, 2010, 115, 2420-9.

Hishiki T., Shimizu Y., Tobita R., Sugiyama K., Ogawa K., Funami K., Ohsaki Y., Fujimoto T., Takaku H., Wakita T., Baumert T.F., Miyanari Y., Shimotohno K. Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J. Virol., 2010, 84, 12048-57.

Imperiale A., Greget M., Chabrier G., Keomany J., Rust E., Detour J., Pessaux P., Goichot B. Solitary hepatic metastasis from medullary thyroid carcinoma mimicking atypical hemangioma: insights from multimodality diagnostic approach by MRI, F-18 FDG and F-18 FDOPA PET/CT. Clin. Nucl. Med., 2010, 35, 434-7.

Mahfud M., Breitenstein S., El-Badry A.M., Puhan M., Rickenbacher A., Samaras P., Pessaux P., Lopez-Ben S., Jaeck D., Figueras J., Alain-Clavien P. Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study. World J. Surg., 2010, 34, 92-100.

Ntourakis D., Marzano E., Lopez Penza P.A., Bachellier P., Jaeck D., Pessaux P. Robotic distal splenopancreatectomy: bridging the gap between pancreatic and minimal access surgery. J. Gastrointest. Surg., 2010, 14, 1326-30.

Pessaux P., Marzano E., Casnedi S., Bachellier P., Jaeck D., Chenard M.P. Histological and immediate postoperative outcome after preoperative cetuximab: case-matched control study. World J. Surg., 2010, 34, 2765-72.

Pessaux P., Marzano E., Rosso E. A plea for the artery-first dissection during pancreaticoduodenectomy. J. Am. Coll. Surg., 2010, 211, 142-3.

Ridereau-Zins C., Aube C., Luet D., Vielle B., Pilleul F., Dumortier J., Gandon Y., Heresbach D., Beziat C., Bailly F., Debilly M., Carbonnel F., Pierredon-Foulongne M.A., Bismuth M., Chretien J.M., Lebigot J., Pessaux P., Valette P.J. Assessment of water enema computed tomography: an effective imaging technique for the diagnosis of colon cancer: Colon cancer: computed tomography using a water enema. Abdom. Imaging, 2010, 35, 407-13.

Marmier-Savet C., Larosa F., Legrand F., Witz B., Michallet M., Ranta D., Louvat P., Puyraveau M., Pouthier F., Deconinck E., Tiberghien P., Robinet E. Persistence of lymphocyte function perturbations after granulocyte-colony-stimulating factor mobilization and cytapheresis in normal peripheral blood stem cell donors. Transfusion, 2010, 50, 2676-85.

Reviews, editorials etc.

Lambotin M., Raghuraman S., Stoll-Keller F., Baumert T.F., Barth H. A look behind closed doors: Interaction of persistent viruses with dendritic cells. Nat. Rev. Microbiol., 2010, 8, 350-60.

Redel L., Le Douce V., Cherrier T., Marban C., Janossy A., Aunis D., Van Lint C., Rohr O., Schwartz C. HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes. J. Leukoc., Biol., 2010, 87, 575-88.

Pfeffer S., Baumert T.F. Antagonizing microRNA-122 and treatment of hepatitis C virus infection. Hepatology, 2010, 51, 1461-3.

Georgel P., Schuster C., Zeisel M.B., Stoll-Keller F., Berg T., Bahram S., Baumert T.F. Virus-host interactions in hepatitis C virus infection – implications for molecular pathogenesis and antiviral strategies. Trends in Molecular Medicine, 2010, 16, 277-86.

Robinet E., Baumert T.F. Host and viral determinants for engraftment of virus permissive human hepatocytes into chimeric immunodeficient mice. J. Hepatol., 2010, 53, 421-3.

Zeisel M.B., Turek M., Baumert T.F. Getting closer to the patient: Upgrade of hepatitis C virus infection in primary human hepatocytes. J. Hepatol., 2010, 53, 388-9.

Mailly L., Le Boeuf C., Tiberghien P., Baumert T.F., Robinet E. Genetically engineered T-cells expressing a gancyclovir-sensitive HSV-TK suicide gene for the prevention of graft versus host disease. Current Opinion in Investigational Drugs, 2010, 11, 559-70.

Moenne-Loccoz R., Razafinjatovo R., Habersetzer F., Ananna A., Doffoel M., Wolf P., Gut J.P., Baumert T., Stoll-Keller F., Schvoerer E. Tropism of hepatitis C virus for leukocytes importance of the analysis of viral E1 and E2 envelope glycoprotein genes by sequencing. Pathol. Biol., 2010, 58, 170-4.

Zeisel M.B., Turek M., Baumert T.F. Impact of tight junction proteins for hepatitis C virus entry. Future Virology, 2010, 5, 263-271.

Pfeffer S., Baumert T.F.  Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection. Gastroentérologie Clinique et Biologique, 2010, 34, 431-5.

Fafi-Kremer S., Habersetzer F., Baumert T.F. Hepatitis C virus entry and glucocorticosteroids. J. Hepatol., 2010, 53, 1148-50.

Henry C., Ramadan A., Montcuquet N., Pallandre J.R., Mercier-Letondal P., Deschamps M., Tiberghien P., Ferrand C., Robinet E. CD3+CD20+ cells may be an artifact of flow cytometry: comment on the article by Wilk et al. Arthritis Rheum., 2010, 62, 2561-3.